You are here:   Home > Work Programme > Early Warning and Emerging Trends

Early Warning and Emerging Trends

This group was originally set up in September 1997 by the Department of Health as the ad hoc Early Warning Committee on New Synthetic Drugs under the 1997 Joint Action by the Council of the European Union concerning information exchange, risk assessment and control of new synthetic drugs where each Member State had to set up a system of early warning on the emergence of this phenomenon. In 2001, the committee was placed on a formal basis within the NACD and its remit extended to include the monitoring of emerging trends.

The Early Warning and Emerging Trends sub-committee is made up of the following members.

Early Warning and Emerging Trends Sub-Committee Members

Mr Gabriel Stanton, Dept of Community, Rural and Gaeltacht Affairs
Dr Des Corrigan, Sch Pharmacy TC
Det Garda Pat Davis, Garda NDU
Dr Daniel O'Driscoll, Forensic Science Laboratory
Mr Gerry Hayes, Dept JELR
Dr Jean Long, Health Research Board
Ms Noreen Quinn, Dept Health & Children
Ms Jackie Blanchfield, St Dominic's Community Response Project
Mr Eamon Corcoran, Department of Health and Children
Ms Aoife Davey, National Drug Strategy Team
Dr Richie Maguire, Medical Bureau of Road Safety
Mr Liam Regan, State Laboratory
Ms Helen Crosse, Toxicology Dept Beaumont Hospital
Dr Bobby Smyth, HSE South Western Area
Ms Siobhan Stokes, Drug Treatment Centre Board
Ms Breda O’Shea, Revenue Commissioners
Ms Niamh Arthur, Irish Medicines Board
Mr Andy Osborn, Crosscare Drug & Alcohol Programme
Dr James Gray, Emergency Dept. AMNCH
Ms Fiona Walsh, HSE Western Area

Home | Contact | Site Map | Search | About the NACD | News and Events | Publications | Research Activities| Work Programme | Research Funding | Submissions | Links | FOI